Charles Schwab’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-318,638
| Closed | -$8.62M | – | 3627 |
|
|
2024
Q2 | $8.62M | Buy |
318,638
+10,171
| +3% | +$275K | ﹤0.01% | 2119 |
|
|
2024
Q1 | $5.65M | Buy |
308,467
+27,250
| +10% | +$499K | ﹤0.01% | 2237 |
|
|
2023
Q4 | $3.45M | Sell |
281,217
-16,927
| -6% | -$208K | ﹤0.01% | 2460 |
|
|
2023
Q3 | $4.47M | Buy |
298,144
+9,667
| +3% | +$145K | ﹤0.01% | 2307 |
|
|
2023
Q2 | $9.37M | Buy |
288,477
+6,145
| +2% | +$200K | ﹤0.01% | 1935 |
|
|
2023
Q1 | $11M | Buy |
282,332
+803
| +0.3% | +$31.4K | ﹤0.01% | 1818 |
|
|
2022
Q4 | $14.9M | Buy |
281,529
+27,629
| +11% | +$1.46M | ﹤0.01% | 1632 |
|
|
2022
Q3 | $11.4M | Buy |
253,900
+5,832
| +2% | +$262K | ﹤0.01% | 1760 |
|
|
2022
Q2 | $9.03M | Sell |
248,068
-4,890
| -2% | -$178K | ﹤0.01% | 1889 |
|
|
2022
Q1 | $10.4M | Buy |
252,958
+8,658
| +4% | +$358K | ﹤0.01% | 1930 |
|
|
2021
Q4 | $10.4M | Buy |
244,300
+4,639
| +2% | +$198K | ﹤0.01% | 1976 |
|
|
2021
Q3 | $13.2M | Buy |
239,661
+3,181
| +1% | +$175K | ﹤0.01% | 1848 |
|
|
2021
Q2 | $11.3M | Buy |
236,480
+17,660
| +8% | +$845K | ﹤0.01% | 1927 |
|
|
2021
Q1 | $11.1M | Buy |
218,820
+7,630
| +4% | +$386K | ﹤0.01% | 1902 |
|
|
2020
Q4 | $13.3M | Buy |
211,190
+5,186
| +3% | +$327K | 0.01% | 1680 |
|
|
2020
Q3 | $13.8M | Buy |
206,004
+78,637
| +62% | +$5.29M | 0.01% | 1463 |
|
|
2020
Q2 | $5.34M | Buy |
127,367
+66,281
| +109% | +$2.78M | ﹤0.01% | 1996 |
|
|
2020
Q1 | $1.92M | Buy |
61,086
+985
| +2% | +$31K | ﹤0.01% | 2288 |
|
|
2019
Q4 | $2.43M | Buy |
60,101
+10,006
| +20% | +$404K | ﹤0.01% | 2359 |
|
|
2019
Q3 | $1.63M | Buy |
50,095
+11,847
| +31% | +$385K | ﹤0.01% | 2451 |
|
|
2019
Q2 | $1.85M | Buy |
+38,248
| New | +$1.85M | ﹤0.01% | 2394 |
|